| Revue: | International braz j urol |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000434905 |
| ISSN: | 1677-5538 |
| Autores: | Wang, Chengtao1 Chen, Zebin1 Dong, Jun1 Wen, Bixiu1 Fang, Yong1 |
| Instituciones: | 1Sun Yat - Sen University, First Affiliated Hospital, Guangzhou, Guangdong. China |
| Año: | 2018 |
| Periodo: | Nov-Dic |
| Volumen: | 44 |
| Número: | 6 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Analítico, descriptivo |
| Resumen en inglés | Objective: To investigate the relationship between the pretreatment body mass index (BMI) and the clinical outcomes in patients with localized stage I - III renal cell carcinoma (RCC) surgically treated. Materials and Methods: From January 2000 to December 2012, 798 patients with stage I - III RCC were recruited from First Affiliated Hospital and Cancer Center of Sun Yat - Sen University. Patients were divided into two groups of BMI < 25 kg / m2 or BMI ≥ 25 kg / m2 according to the World Health Organization classifications for Asian populations. The differences in the long-term survival of these two BMI groups were analyzed. Results: The 5 - year failure - free survival rates for BMI < 25 kg / m2 and BMI ≥ 25 kg / m2 groups were 81.3% and 93.3%, respectively (P = 0.002), and the 5 - year overall survival rates were 82.5% and 93.8%, respectively (P = 0.003). BMI was a favored prognostic factor of overall survival and failure - free survival in a Cox regression model. Conclusions: Pretreatment body mass index was an independent prognostic factor for Chinese patients surgically treated, localized stage I - III RCC |
| Disciplinas: | Medicina |
| Palabras clave: | Oncología, Nefrología, Carcinoma de células renales, Indice de masa corporal, Factores pronósticos |
| Keyword: | Oncology, Nephrology, Renal cells carcinoma, Body mass index, Prognostic factors |
| Texte intégral: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
